IBEX Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

IBEX Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,000	Closed	-$13K	–	430
2019 Q2	$13K	Buy	+1,000	New	+$15K	﹤0.01%	309

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

IBEX Wealth Advisors's IMMU Position: Q3 2019 in Review

IBEX Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 1,000 shares — an estimated $13K sold.

IBEX Wealth Advisors first reported a position in IMMU in Q2 2019 and held it in 1 quarter. The position peaked at $13K in Q2 2019. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

IBEX Wealth Advisors reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
IBEX Wealth Advisors sold 1,000 Immunomedics Inc shares in Q3 2019, an estimated $13K.
IBEX Wealth Advisors first reported a position in Immunomedics Inc in Q2 2019 and held it in 1 quarter.
IBEX Wealth Advisors's Immunomedics Inc position peaked at $13K in Q2 2019.
208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on IBEX Wealth Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.